A reference of the terms used throughout PEMF therapy, bioregulation, and electromagnetic medicine, written for both patients and practitioners.
A non-invasive therapeutic modality that delivers low-frequency electromagnetic pulses to the body, typically between 0.5–30 Hz, to stimulate cellular repair, increase ATP production, reduce inflammation, and support natural healing processes.
A class of therapies (including PEMF and biofeedback-driven devices) that work with the body's own bioelectric signals to restore physiological self-regulation rather than imposing external chemical changes.
The body's intrinsic ability to maintain homeostasis through electromagnetic, biochemical, and neurological signaling. Bioregulation devices aim to support or restore these natural feedback loops.
A modality based on the principle that cells and tissues emit characteristic electromagnetic frequencies, and that resonant stimulation can support cellular communication and balance.
A technique in which sensors measure physiological signals (heart rate, brainwaves, EMG, EMF) and feed them back to the user or device in real time, enabling adaptive responses such as BRT signal modification.
The primary energy currency of every living cell. PEMF therapy has been shown to increase cellular ATP production by 20–40%, supporting healing, recovery, and metabolic function.
The voltage difference across a cell's membrane, typically -70 to -90 millivolts in healthy cells. Damaged or diseased cells lose charge; PEMF helps restore optimal membrane potential.
The energy-producing organelles inside cells. PEMF therapy enhances mitochondrial function and ATP synthesis, which underlies many of its systemic effects on energy, sleep, and recovery.
A signaling molecule that dilates blood vessels and improves circulation. PEMF stimulates nitric oxide release, enhancing microcirculation and oxygen delivery to tissues.
The variation in time between consecutive heartbeats. Higher HRV indicates better autonomic nervous system balance; PEMF and vagal-tone protocols have been shown to improve HRV.
The 'rest and digest' branch of the autonomic nervous system. Low-frequency PEMF (delta and theta range) activates parasympathetic dominance, supporting sleep, recovery, and stress reduction.
The longest cranial nerve and the primary conduit of the parasympathetic system. PEMF and BRT can stimulate vagal tone to support mood, digestion, inflammation, and HRV.
Signaling proteins that regulate inflammation and immune response. PEMF therapy can downregulate pro-inflammatory cytokines and modulate immune function.
The body's 24-hour biological clock governing sleep, hormones, and metabolism. Specific PEMF frequencies (delta range) help entrain healthy circadian patterns.
A biological dose-response principle: weak stimuli activate physiological activity, moderate stimuli enhance it, strong stimuli inhibit it, and very strong stimuli abolish it. PEMF research consistently replicates this curve, with optimal cellular response in the 1–100 microtesla range, supporting the clinical superiority of low-dose, biofeedback-guided PEMF over high-intensity PEMF.
PEMF delivered at low intensity (typically 1–100 microtesla) and low frequency, consistent with the Arndt-Schulz dose-response optimum. All foundational FDA-cleared PEMF indications (non-union fractures, post-operative edema, and treatment-resistant depression) were cleared at low intensities, not high-Tesla outputs.
A therapy architecture in which the device continuously captures the patient's own physiological signals, modifies them via algorithms, and returns them in real time. BRT devices like the CellCom implement closed-loop biofeedback over the 1 Hz–1 MHz electromagnetic spectrum, producing more personalized and durable outcomes than open-loop, pre-programmed PEMF.
A unit of frequency equal to one cycle per second. Clinical PEMF operates at 0.5–30 Hz, matching the body's natural bioelectric rhythms.
Units of magnetic flux density. 1 Tesla = 10,000 Gauss = 1,000,000 microtesla. Home PEMF mats are typically under 100 microtesla; clinical machines can reach 1–2 Tesla peak.
The Earth's natural electromagnetic frequency, approximately 7.83 Hz. Many PEMF protocols include Schumann-aligned frequencies for grounding and circadian support.
The brain's tendency to synchronize its electrical activity to external rhythmic stimuli, including PEMF pulses. The basis for entraining specific brainwave states (delta, theta, alpha, beta).
Brainwaves in the 0.5–4 Hz range associated with deep, restorative sleep. PEMF delta protocols support sleep onset and slow-wave sleep depth.
Brainwaves in the 4–8 Hz range linked to deep relaxation, meditation, and creativity. Used in PEMF protocols for stress reduction and emotional balance.
Brainwaves in the 8–12 Hz range associated with calm, focused alertness. PEMF alpha protocols support anxiety reduction and present-moment awareness.
Brainwaves in the 12–30 Hz range associated with active thinking and focus. Higher-frequency PEMF can support cognitive performance and alertness.
A smooth, oscillating waveform shape commonly used in clinical PEMF devices for biocompatibility and gentle cellular stimulation.
A sharp on/off pulse pattern used in some PEMF devices for stronger stimulation; better suited to clinical settings than daily use.
A flat, full-body PEMF applicator designed for whole-body sessions. Generally lower intensity than clinical machines and well-suited to daily home use for sleep, wellness, and recovery.
A clinical-grade PEMF system with localized applicators and higher intensities (often 1+ Tesla) used by practitioners for targeted pain, injury, and bone-healing protocols.
A focused PEMF accessory (paddle, ring, or localized coil) that concentrates the magnetic field over a specific body area such as a joint or injury site.
A device whose manufacturer is registered with the U.S. FDA and that meets applicable regulatory standards for its listed indications. BioReg devices are FDA registered.
BioReg's flagship bioregulation therapy device that uses six ultra-sensitive electrodes to capture, analyze, and modify the body's own EMF signals across 1 Hz–1 MHz in real time.
BioReg's quad-channel professional PEMF system with 48 programmable settings, designed for clinical practitioners.
Pain persisting beyond 3 months. PEMF therapy supports chronic pain by reducing inflammation, improving circulation, and modulating pain signaling at the cellular and nervous-system level.
A chronic disorder characterized by widespread musculoskeletal pain, fatigue, and sleep disturbance. PEMF is studied as a complementary modality for symptom management.
A bone fracture that fails to heal within expected timeframes. PEMF received its first FDA clearance in 1979 specifically for non-union fracture healing.
A condition of reduced bone density. PEMF therapy supports osteoblast activity and is studied as a non-pharmacological adjunct for bone health.